In August 2021 Finfeed changed from a website that covered ASX listed news to a website
that covered a select range of ASX
listed small cap Biotech stocks that we are personally invested in: find out more.
The old Finfeed website, and all of the old articles are kept here for record keeping purposes.VISIT NEW SITE
Roots targets the high growth organic plant-based ‘meat’ market
5 minute read
Consumers are quickly waking up to the fact that consuming meat — especially highly processed meat — can have negative health outcomes and is contributing to the destruction of the environment.
Recognising both the health and environmental upsides of eating plant-based meat alternatives is translating to commercial success for businesses savvy enough to capitalise on this early trend.
With a market cap of almost US$7 billion, none have been more successful than Beyond Meat (NASDAQ: BYND).
Beyond Meat’s burgers and other plant-based products appeal not only to vegetarians, vegans, and the environmentally conscious, but they have now received official kosher certification. In a major coup, last month the company was selected by McDonald’s to supply the patties for burger its burger chains. The burgers will be known as P.L.T. burgers.
Also capitalising on the trend is the Bill Gates backed Impossible Foods, which just raised US$700 million from US venture capital firms to further its plant-based meat offerings.
Impossible Foods’ sells its burgers in US supermarkets and supply a number of major fast food outlets, including the country’s second largest fast food company, Burger King.
Its plant-based Impossible Burger “bleeds” like the real thing. Yet, it’s made from soy and potato proteins and its signature ingredient — the iron-rich compound, heme. Heme is produced when soy leghemoglobin is cooked and gives the veggie burger a meat-like flavour and its bleeding look.
However, plant-based meats may not be as healthy or environmentally friendly as it seems.
The industry relies heavily on industrially grown, high protein crops including soy, pea and potatoes, which require heavy use of herbicides and pesticides. This is the case for producers Beyond Meat and Impossible Foods and is one of the major criticisms they face.
For that reason, there’s growing demand for organically grown and environmentally conscious options for consumers.
Roots Sustainable Agricultural Technologies Ltd (ASX:ROO) addresses critical problems being faced by agriculture, including plant climate management and the shortage of water for irrigation.
Importantly, its technologies can assist in growing high-end organic meat replacement crops.
Roots has expanded into the plant-based meat market, initiating a planting program to examine the effects of its Root Zone Temperature Optimization (RZTO) and Irrigation by Condensation (IBC) technologies on several protein-laden crops to increase the content of leghemoglobin.
Its technologies work to increase a crop's leghemoglobin – also known as “heme” — a form of haemoglobin in plants and the key ingredient in what makes plant-based meats so tasty.
Stabilising plants’ root temperatures stimulates their immune systems, reducing susceptibility to pathogens and increasing the total biomass, and therefore potentially increasing total protein content.
Off the back of this discovery, ROO intend to lead the organic segment of the artificial meat replacement industry.
Roots is examining crops with a high protein content, either in the roots or in the canopy, which can be grown year-round using its RZTO technology. High end protein laden crops can be grown indoors where organic methods and cater for a lucrative organic meat replacement niche.
Roots will formally test the concept on high protein crops already planted at the company’s farm in Bet Halevi, Israel. Two high protein crops were planted in September 2019 using three configurations of the RZTO technology — horizontal, “Stub T-shape”, and a control group.
The final RZTO results from the first stage of the program are expected in November. Success here could lead to the planting of smaller size fields and greenhouses, thereby creating cost efficiencies and increasing profits for farmers using the RZTO system.
Roots’ planting program and potential technological breakthrough has already generated interest.
Discussions are underway with a European consultancy group and a bio-based company on a potential common application for a bi-national grant between Israel and Holland. The application will involve three companies, two of which must be European based.
The company is also assessing other potential opportunities to leverage its technology in the artificial meats space.
Roots CEO, Dr Sharon Devir said, “Increasing consumer concerns about the environmental and health impacts of meat coupled with a changing approach from the food industry to create meat alternatives has contributed to the large growth in the meat-replacement market.
“Our technology enables year-round production with relative low energy demand, decreasing the environmental impact. The organic meat replacement segment is emerging as a significant opportunity for Roots’ root zone heating and cooling technology and we see benefits for high-value crops grown indoors organically.”
Roots secures funding in placement
On Wednesday Roots announced that it had completed a $820,000 capital raising to sophisticated and professional investors.
The placement will see Roots issue 19,069,767 CDIs at A$0.043 each — a 15% discount to the 30-day volume weighted average price (VWAP) to 18 October 2019.
This comes after the company’s $1.66 million equity raising in May, which, after significant delays in seeking shareholder approval, resulted in a shortfall. This week’s equity raising is a result of that shortfall as well as ongoing needs.
This is a strong endorsement of Roots opportunities to commercialise its RZTO growth and will assist in expanding its marketing to cannabis growers and sales activity in the US.
Commenting on the placement Devir said, “We would like to welcome our new investors onto our register and recognise the continued support of our existing investors who participated.
“The placement is a strong endorsement of our substantial opportunities to commercialise our RZTO technology across multiple geographies, as we build on the momentum gained from initial sales. The funding secured in this placement will allow us to accelerate our growth in the US cannabis market, over the medium term.”